NCT03954795

Brief Summary

The aim of the study is to compare the effectiveness and opioid sparing effects of TAP and OSTAP in patients undergoing laparoscopic cholecystectomy.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
75

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Sep 2014

Typical duration for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2014

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2016

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2016

Completed
2.8 years until next milestone

First Submitted

Initial submission to the registry

May 14, 2019

Completed
3 days until next milestone

First Posted

Study publicly available on registry

May 17, 2019

Completed
Last Updated

May 21, 2019

Status Verified

May 1, 2019

Enrollment Period

1.7 years

First QC Date

May 14, 2019

Last Update Submit

May 17, 2019

Conditions

Keywords

TAP OSTAP Postoperative pain

Outcome Measures

Primary Outcomes (3)

  • Change in postoperative pain scores throughout time evaluated by VAS

    Pain scores are going to be evaluated via VAS score. The VAS score will be scored between 0-10. 0 points is defined as no pain and 10 points is the most severe pain imaginable by the patient. A higher VAS score reflects a poor pain control.

    Pain scores will be recorded for 24 hours postoperatively. The first measure will be taken immediately after surgery (time 0) and then at 2. 4. 6. 12. 24. hours.

  • Change in opioid Sparing effect measured through morphine amount delivered by a patient controlled analgesia device.

    The amount of morphine demand of the patient measured through morphine delivery by the patient controlled analgesia device

    The amount of Morphine demanded by the patient will be recorded for 24 hours postoperatively. The first measure will be taken immediately after surgery (time 0) and then at 2. 4. 6. 12. 24. hours.

  • Amount of total intraoperative remifentanil infusion

    The total amount of infused remifentanil throughout the surgery will be recorded from the infusion device.

    At the end of surgery.

Study Arms (3)

Group 1: TAP Block

ACTIVE COMPARATOR

TAP Block performed from the petit triangle ( anterior axillary line and iliac crest.)

Procedure: TAP

Group 2: OSTAP Block

ACTIVE COMPARATOR

Modified TAP (OSTAP) block performed from the medial of linea semilunaris applying local anesthetic to the area between xiphoid and anterior iliac crest.

Procedure: OSTAP

No Block

NO INTERVENTION

No interventions

Interventions

TAPPROCEDURE

Classic TAP block performed through the petit triangle (the anterior axillary line and iliac crest)

Group 1: TAP Block
OSTAPPROCEDURE

Modified TAP (OSTAP) block performed from the medial of linea semilunaris applying local anesthetic to the area between xiphoid and anterior iliac crest.

Group 2: OSTAP Block

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Scheduled for laparoscopic cholecystectomy
  • ASA status I-II

You may not qualify if:

  • Local anesthetic allergy
  • Coagulopathy
  • Infection at procedure site

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Pain, Postoperative

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
associated professor

Study Record Dates

First Submitted

May 14, 2019

First Posted

May 17, 2019

Study Start

September 1, 2014

Primary Completion

May 1, 2016

Study Completion

August 1, 2016

Last Updated

May 21, 2019

Record last verified: 2019-05